Haleon completes acquisition of remaining 12% in China joint venture
(Alliance News) - Haleon PLC on Friday said it completed the acquisition of the remaining 12% equity interest in Tianjin TSKF Pharmaceutical Co Ltd, its over-the-counter joint venture in China. Read More